Synthesis and Evaluation of Isatin Analogs as Potential Urease and Tyrosinase Inhibitors: An Approach of Molecular
Guoyang Ma1, Yawen Li2, Shaohong Xu2
1School of Chemistry & Materials Engineering, Xinxiang University, Xinxiang, Henan, China.
Synthesized isatin-based Schiff base derivatives show moderate urease inhibition. Compounds 1, 3, and 10 exhibit potential as lead compounds for novel urease inhibitors, with compound 1 showing the strongest activity.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Enzyme Inhibition
Background:
- Urease and tyrosinase are enzymes implicated in various biological processes and diseases.
- Isatin-based Schiff bases are a class of compounds with diverse pharmacological activities.
- Developing novel inhibitors for urease and tyrosinase is of significant therapeutic interest.
Purpose of the Study:
- To synthesize and characterize a series of novel isatin-based Schiff base derivatives.
- To evaluate the urease and tyrosinase inhibitory potential of the synthesized compounds.
- To establish structure-activity relationships and explore binding interactions through molecular docking.
Main Methods:
- Two-step synthesis of isatin-based Schiff base derivatives.
- Characterization using 1H-NMR and mass spectrometry.
- In vitro enzyme inhibition assays for urease and tyrosinase.
- Structure-activity relationship (SAR) analysis.
- Molecular docking studies.
Main Results:
- Twelve isatin-based Schiff base derivatives were synthesized and characterized.
- Compounds 1, 3, and 10 demonstrated moderate urease inhibition, with IC50 values of 38.9, 56.7, and 71 µM, respectively.
- All synthesized compounds were inactive against tyrosinase.
- Molecular docking revealed strong binding interactions of compound 1 with the urease active site, indicated by a docking score of -4.8944.
Conclusions:
- The synthesized isatin-based Schiff base derivatives possess moderate urease inhibitory activity.
- Compounds 1, 3, and 10 are identified as promising lead compounds for the development of new urease inhibitors.
- Further investigation into these compounds could lead to novel therapeutic agents.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Enzyme Inhibition
Ligand Binding and Linkage
